Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 31-33, January 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanni, R.
Right arrow Articles by Faa, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanni, R.
Right arrow Articles by Faa, G.

Endometrial Polyps with Predominant Stromal Component Are Characterized by a t(6;14)(p21;q24) Translocation

Roberta Vanni1, Susanna Marras, Marcello Andria and Gavino Faa

Istituto di Biologia Generale [R. V., S. M.], Via Ospedale, 119 09124 Cagliari (Sardinia), Italy, Dipartimento di Citomorfologia, Sezione di Anatomia Patologica [G. F.], and Division Ostetrica e Ginecologica USL 21 [M. A.], Cagliari, Italy

Cytogenetic investigation of endometrial polyps revealed the presence of a t(6;14)(p21;q24) as the sole abnormality in three cases. All tumors showed a histopathological pattern of predominant stromal hyperplasia with scarce representation of glandular elements, suggesting that a cytogenetic subgroup characterized by the t(6;14) translocation can be associated with endometrial polyps with a preponderant component of mesenchymal origin.

1 To whom requests for reprints should be addressed.

Received 9/29/94. Accepted 11/14/94.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
G L Mutter
Diagnosis of premalignant endometrial disease
J. Clin. Pathol., May 1, 2002; 55(5): 326 - 331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.